Abbott profit forecast gets a lift from St. Jude integration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St up after tech selloff as yields retreat; Moderna surges
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Abbott Labs (ABT) PT Raised to $56 at Deutsche Bank Following 2Q
July 21, 2017 8:37 AM EDTDeutsche Bank raised its price target on Abbott Labs (NYSE: ABT) to $56.00 (from $49.00) while maintaining a Buy rating following 2Q earnings report.... More
Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'
July 21, 2017 8:32 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) while maintaining a Overweight rating, following the company's second quarter earnings announcement.
Analyst Matthew Taylor notes the company delivered second quarter earnings per share and revenue results above the Street's... More
Abbott Labs (ABT) PT Raised to $62 at Argus on 2Q Beat & FY17 Raise; 'Positive View of Growth Prospects'
July 21, 2017 7:45 AM EDTArgus raised its price target on Abbott Labs (NYSE: ABT) to $62.00 (from $55.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst David Toung notes the company delivered second quarter earnings per share above consensus projections driven by positive... More
